Navigation Links
MDMA Board Unanimously Opposes Medical Device Tax
Date:10/9/2009

Patient Care, Innovation, Investment and Jobs Will Suffer

WASHINGTON, Oct. 9 /PRNewswire-USNewswire/ -- Yesterday, the Medical Device Manufacturers Association Board of Directors met and unanimously voted to oppose any device tax as part of the health care reform bills moving through Congress. MDMA Chairman Joe Kiani, Chairman and CEO of Masimo Corporation, stated that, "MDMA supports bipartisan legislation to improve patient care, reform the insurance industry and promote prevention and wellness. The current medical device tax being discussed on Capitol Hill will hinder achieving these objectives. The overwhelming majority of innovation from the medical device industry comes from smaller manufacturers who work closely with clinicians and engineers to develop the therapies and treatments of tomorrow. If enacted, this tax will stifle innovation, harm patient care and weaken the position of the US as the global leader in medical device innovation."

(Logo: http://www.newscom.com/cgi-bin/prnh/20041004/MDMALOGO)

Earlier this week MDMA executives and members met with members of Congress to communicate their concerns about the device tax. In a statement, MDMA President and CEO, Mark Leahey, said, "There can be little doubt -- the proposed tax will have a cascading effect upon innovation, access to technology and employment in the industry."

On Tuesday, MDMA sent a letter to Senate Finance Chairman Max Baucus and Ranking Member Charles Grassley expressing its "steadfast opposition" to the tax and stated that "if enacted, this fee would have a devastating impact on innovation, investment and the nation's economy." The letter went on to say, "it is not a proposal supported by the overwhelming majority of the device industry."

It has been suggested that medical device companies need to contribute cuts to help make up for the costs of expanding coverage. This is in addition to other elements of the bill, including the $155B in payment reduction to hospitals that will already adversely impact the medical device industry. Additionally, proposed cuts in the areas of imaging, durable medical equipment and clinical lab supplies are also included in the bill.

Furthermore, claims that the taxes levied on medical device companies will be offset due to an increased pool of insured beneficiaries receiving treatment are overstated. Since the majority of products impacted are used in acute care settings where there are legal obligations to treat a patient, the effect of expanded coverage is not likely to increase utilization. In fact, if the bill succeeds in improving the health of Americans, procedures and interventions will likely be reduced.

MDMA President and CEO Mark Leahey went on to state, "In the coming weeks our hundreds of member companies across the country will do all we can to communicate the detrimental impact this fee will have on achieving the long term objectives of health care reform. The bill should include provisions that promote innovation and improve patient care, not harm the system."

MDMA is a national trade association representing innovative small and mid-size medical technology companies. Our hundreds of member companies across 36 states seek to promote policies that provide patients and clinicians with timely access to safe and effective products.

SOURCE Medical Device Manufacturers Association


'/>"/>
SOURCE Medical Device Manufacturers Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
2. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
3. American Board of Internal Medicine President Named to Alzheimers Study Group
4. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
5. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
6. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
7. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
8. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
9. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
10. Silence Therapeutics Announces Board Changes
11. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2017)... BELL, Pa. , June 1, 2017 ... (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma ... investment in Nutriceutical Holdings by KD Pharma Group. KD ... Holdings with the option to acquire the entire company. ... partner in KD. They are committed to growing the ...
(Date:5/29/2017)... 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... enables the functional selection of stem cells, today provided ... first quarter ended March 31 st , 2017. ... in the first quarter of 2017," said Dr. Shai ... announced the treatment of the first blood cancer patient ...
(Date:5/23/2017)... Calif. , May 23, 2017  Leaf ... most innovative medical devices for pressure ulcer prevention, ... the American Association of Critical Care Nurses, National ... May 22-25. The Leaf Patient Monitoring ... specifically for the hospital environment.  The system seamlessly ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... American Farmer, will feature Chr. Hansen, Inc (CHR ... air fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your ... Chr. Hansen in Denmark in 1874 after a groundbreaking discovery of how to industrialize ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... and related services to families and business owners in and around Lackawanna County, ... benefit senior citizens in the area. , Meals on Wheels of NEPA provides ...
(Date:6/23/2017)... ... ... All-Star Insurance, a family managed agency that offers insurance management assistance and personal ... of a new charity drive to benefit women in the area diagnosed with breast ... estimated 252, 710 new cases of invasive or high risk breast cancer will be ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... in the Houston area with access to asset protection and financial planning services, ... event aimed at improving the lives of children with cancer and other chronic ...
(Date:6/22/2017)... ... June 22, 2017 , ... Plastic Surgery Associates is proud to report that ... Each year, research and information firm, Castle Connolly, releases their list of the most ... marks the 3rd time that Dr. Canales has been recognized by Castle ...
Breaking Medicine News(10 mins):